Literature DB >> 15154692

Equity weights in the allocation of health care: the rank-dependent QALY model.

Han Bleichrodt1, Enrico Diecidue, John Quiggin.   

Abstract

This paper introduces the rank-dependent quality-adjusted life-years (QALY) model, a new method to aggregate QALYs in economic evaluations of health care. The rank-dependent QALY model permits the formalization of influential concepts of equity in the allocation of health care, such as the fair innings approach, and it includes as special cases many of the social welfare functions that have been proposed in the literature. An important advantage of the rank-dependent QALY model is that it offers a straightforward procedure to estimate equity weights for QALYs. We characterize the rank-dependent QALY model and argue that its central condition has normative appeal.

Mesh:

Year:  2004        PMID: 15154692     DOI: 10.1016/j.jhealeco.2003.08.002

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  14 in total

1.  Prioritizing risk factors to identify preventive interventions for economic assessment.

Authors:  Nick Wilson; Tony Blakely; Rachel H Foster; David Hadorn; Theo Vos
Journal:  Bull World Health Organ       Date:  2011-10-14       Impact factor: 9.408

2.  Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall.

Authors:  Elly A Stolk; Gijs van Donselaar; Werner B F Brouwer; Jan J V Busschbach
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 3.  Cost-effectiveness of neonatal surgery: first greeted with scepticism, now increasingly accepted.

Authors:  Marten J Poley; Werner B F Brouwer; Jan J V Busschbach; Frans W J Hazebroek; Dick Tibboel; Frans F H Rutten; Jan C Molenaar
Journal:  Pediatr Surg Int       Date:  2007-11-06       Impact factor: 1.827

4.  The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.

Authors:  Paul A Scuffham; Jennifer A Whitty; Andrew Mitchell; Rosalie Viney
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 5.  Methods for measuring temporary health States for cost-utility analyses.

Authors:  Davene R Wright; Eve Wittenberg; J Shannon Swan; Rebecca A Miksad; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 6.  Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review.

Authors:  Vadim Dukhanin; Alexandra Searle; Alice Zwerling; David W Dowdy; Holly A Taylor; Maria W Merritt
Journal:  Soc Sci Med       Date:  2017-12-14       Impact factor: 4.634

7.  Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.

Authors:  Thomas Ward; Ruben E Mujica-Mota; Anne E Spencer; Antonieta Medina-Lara
Journal:  Pharmacoeconomics       Date:  2021-10-29       Impact factor: 4.981

Review 8.  Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.

Authors:  Lisa A Prosser; James K Hammitt; Ron Keren
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

9.  A cost-based equity weight for use in the economic evaluation of primary health care interventions: case study of the Australian Indigenous population.

Authors:  Katherine S Ong; Margaret Kelaher; Ian Anderson; Rob Carter
Journal:  Int J Equity Health       Date:  2009-10-07

10.  Efficient and equitable HIV prevention: A case study of male circumcision in South Africa.

Authors:  Stéphane Verguet
Journal:  Cost Eff Resour Alloc       Date:  2013-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.